__NUXT_JSONP__("/drugs/Semaxanib", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"194413-58-6",chebiId:"",chemicalFormula:"C15H14N2O",definition:"A quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells.",fdaUniiCode:"71IA9S35AJ",identifier:"C1831",preferredName:a,semanticType:"Organic Chemical",subclassOf:[],synonyms:["H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-","SEMAXANIB","SU 5416","SU5416",a,"Semoxind","Sugen 5416","semaxanib"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSemaxanib",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Semaxanib","2021-10-30T13:36:49.523Z")));